May 10, 2021
Since 2019 Bicoll GmbH has supported Galyan Bio Inc. in developing and optimizing an orally available small molecule for Huntington's Disease Target. Clinical trials are scheduled for 2022.
![]()
Planegg, Germany - May 10, 2021 /PressCable/ —
Planegg / Martinsried (Germany), Bicoll, an expert in synthesizing new and relevant small molecules as starting points for accelerated drug development, announced today its supporting role in the development of novel drug candidates for Huntington’s disease in collaboration with Galyan Bio.
Huntington’s disease is a progressive brain disorder that causes involuntary movements, emotional problems, and loss of thinking ability (cognition). Early signs and symptoms can include irritability, depression, uncontrolled movements, and poor coordination. Huntington’s disease is caused by mutations in the HTT gene which encodes a protein called huntingtin (HTT). Among many other essential functions in neurons, huntingtin plays a critical role in neuronal survival, transport of synaptic proteins and function of cilia sensory organelles that control CSF flow. Huntington’s disease affects an estimated 3 to 7 per 100,000 people of European ancestry.
Galyan Bio Inc., a start-up company in California (USA), is developing first-in-class orally available small molecules for neurodegenerative diseases. Working in close collaboration with Bicoll GmbH since 2019, Galyan Bio discloses now to have a drug candidate, which is intended to slow down the disease in symptomatic patients and delay the manifestation of Huntington disease in symptom-free gene carriers. The start of clinical trials is scheduled for 2022.
“This collaboration once again highlights the wide spectrum of areas where small molecules demonstrate their proven track record. Decades of experience of Bicoll’s synthetic and analytic team have enabled the fast pace optimization program that led to a drug candidate for Galyan Bio. Bicoll is proud of its support to Galyan Bio in all stages of preclinical testing and development, including scaling up of the initial active compounds to multigram scale. Our team is delighted to have contributed to this set of new, patented compounds, which is representing a promising new class of powerful Huntington’s disease drug candidates. We are looking forward to the outcome of the planned clinical trials” said Bicoll GmbH Managing Director Dr. Kai Lamottke.
Dr. Marius Galyan stated: “Bicoll’s continuous support towards integrated small molecule synthesis service combined with ADMET determination enhanced the speed of compound screening rounds considerably. Furthermore, Bicoll’s support in addressing solubility and stability issues of our screening compounds brought us to this success.”
About Bicoll
The Bicoll Group is a privately-owned biopharmaceutical company which includes Bicoll GmbH headquartered near Munich in Planegg / Martinsried, Germany, and its wholly-owned subsidiary Bicoll Biotechnology (Shanghai) Co. Ltd.
Bicoll offers pre-clinical support with an efficient, multi-disciplinary approach to drug discovery. Dedicated to the discovery and optimization of the highest quality lead compounds, Bicoll provides services to international clients in the pharmaceutical, agrochemical, and related industries. The unique combination of expertise in high-tech natural product chemistry and medicinal chemistry, enables Bicoll to increase the quality and quantity of the drug discovery pipeline of partner’s candidate portfolios.
About Galyan Bio
Galyan Bio Inc. is a start-up company located on Berkeley, California (USA). Galyan is developing first-in-class orally available small molecules for neurodegenerative diseases, cancer and aging. It was founded in 2019 by Dr. Marius Galyan.
Contact Info:
Name: Maria Lamottke
Email: Send Email
Organization: Bicoll GmbH
Address: 19 Am Klopferspitz, Planegg, Bayern 82152, Germany
Phone: +49-89-82010630
Website: https://bicoll-group.com
Source: PressCable
Release ID: 89010518
From sailing to the remote islands of French Polynesia and exploring Japan’s ancient Zen traditions to riding a historic steam train through Colorado’s Wild West, some adventures are simply too good to miss, whatever your age. For travellers in their 50s, 60s, 70s and beyond, 2027 offers plenty of opportunities to discover somewhere new, revisit places that hold special memories or finally embark on a long-dreamed-of journey. Whether it’s retracing the footsteps of Elvis Presley in Memphis 50 years after his death, discovering the wild landscapes of Florida’s Everglades or taking the scenic route to the French Alps aboard a sleeper train, these 12 unforgettable holidays prove that a sense of adventure never gets old.
Global tourism is entering a new era of strategic choices. The industry is still generating economic growth, but geopolitical instability, climate pressures, investment challenges and technological disruption are testing its long-term competitiveness. The numbers reveal a paradox. According to the World Economic Forum’s Travel & Tourism Development Index 2026, 92% of the 110 economies assessed have improved their conditions for tourism development since 2024. The World Travel & Tourism Council (WTTC) forecasts a US$12 trillion contribution to the global economy in 2026, supporting around 376 million jobs.
“I think about quitting all the time,” says Jordan Leung, known to his Instagram followers as @69ranch. As one of Hong Kong’s most prominent stand-up comedians to emerge in recent years, Leung’s pessimism is surprising. “I don’t wanna make social media content,” the 33-year-old admits. “Now I’m just fixated on likes and stuff … I don’t know how much longer I can do this.” Sitting directly across the table from him, it is not always easy to tell when Leung is being sincere or performing his...
There's no need to panic in a random gas station without TP when these handy portable wipes exist. View Entire Post ›
I loveeeee a British breakfast! View Entire Post ›
For a while, the blueprint for a serious wellness trip looked pretty much the same everywhere. A flight to somewhere warm, a resort with a view of jungle or terraced rice paddies, a treatment menu borrowing names from ancient traditions, and enough linen to last a lifetime. Scotland was never really part of that picture. It was the place people went for whisky, castles and rain, not the place they went to reset. Then this summer, Scotland’s men’s football team appeared at their first World Cup...
If you feel lost or overwhelmed now your children have left the nest, you are far from alone. Many parents experience empty nest syndrome at this time of the year. “Empty nest syndrome isn’t a mental health condition, but a set of feelings or symptoms that parents might feel when all their children have left home,” says Dr Elizabeth Wakeland, consultant, clinical and forensic psychologist at Cygnet Health Care in the UK. “It’s a period of significant life change where parents are trying to...
A powerful, brief downpour sent Disneyland visitors scrambling for cover Friday night, closed rides and flooded parts of Frontierland as workers tried to clear backed-up drains.
Make your travel plans with your pup a walk in the park. View Entire Post ›
With Clayface, DC trades its usual cape-donning heroes for a chilling entry into body-horror cinema. Starring Tom Rhys Harries, the film follows Matt Hagen (played by Harries), a Hollywood star from Gotham whose run-in with a crime boss leaves his face severely disfigured. Desperate to restore himself, Hagen turns to Dr. Caitlyn Corr (Naomi Ackie), whose experimental treatment makes matters worse. So Hagen finds himself on a path from Hollywood’s charming leading man to a Gotham City...
The historic Mt. Waterman Ski Resort, one of Southern California's steepest ski resorts and only an hour from downtown Los Angeles, was relisted for sale on Wednesday at $3,275,000.
If you know, you really know. View Entire Post ›
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.